A compound of formula (I) N-oxide, stereoisomers, tautomers, solvates or a pharmaceutically-acceptable salt thereof, wherein: G is: (i) (ii) (iii) or (iv) a 9-membered heterocyclic ring selected from: A is -L-R 6; L is a bond, -CH 2 -, -CH 2 CH 2 -, -CH 2 C(O)-, -CH 2 C(O)NH-, -CH 2 C(O)N(CH 3 )-, -CH 2 C(O)NHCH 2 -, or -CH 2 C(O)NHCH 2 CH 2 -; R 1 is -CH 2 CH 3 or -CH(CH 3 ) 2 ; each R 2 is independently -CH 3 or -OCH 3 ; R2a is -CH 3 ; each R 2b is independently H, Cl, or -CH 3 ; R 6 is: (i) -CH 2 C(O)NHCH 2 C(CH 3 ) 2 OH, -CH 2 C(O)NHCH 2 CH 2 C(CH 3 ) 2 OH, -CH 2 C(O)NHCH 2 CH 2 NH 2 , or -CH 2 C(O)NHCH 2 CHFC(CH 3 ) 2 OH; or (ii) azabicyclo[3.2.1]octanyl, azaspiro[5.5]undecanyl, azetidinyl, cyclohexyl, diazabicyclo[2.2.1]heptanyl, diazaspiro[3.5]nonanyl, imidazolyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, phenyl, piperazinyl, piperidinyl, pyrrolidinyl, pyridinyl, or quinuclidinyl, each substituted with zero to 2 R 6a ; each R 6 a is independently F, -OH, -CH 3 , -CH 2 CH 2 CH 3 , -C(CH 3 ) 2 , -CH 2 CH(CH 3 ) 2 , -CH 2 CH 2 CF 3 , -CH 2 CH 2 CH 2 CF 3 , -CH 2 CH 2 OH, -CH 2 CH 2 CH 2 OH, -CH 2 CH(CH 3 )OH, -CH 2 C(CH 3 ) 2 OH, -CH 2 CH 2 OCH 3 , -NH 2 , -N(CH 3 ) 2 , -CH 2 NH 2 , -CH 2 CH 2 NH 2 , -CH 2 CH 2 S(O) 2 CH 3 , -CH 2 C(O)OH, -CH 2 C(O)N(CH 3 ) 2 , -C(O)CH 2 N(CH 3 ) 2 , -CH 2 (phenyl), morpholinyl, oxetanyl, tetrahydropyranyl, piperidinyl, isopropylpiperidinyl, isobutylpiperidinyl, or -O(piperidinyl); n is zero; and p is zero. G is: (i) (ii) (iii) or (iv) a 9-membered heterocyclic ring selected from: (i) (ii) (iii) or (iv) a 9-membered heterocyclic ring selected from: A is -L-R 6; L is a bond, -CH 2 -, -CH 2 CH 2 -, -CH 2 C(O)-, -CH 2 C(O)NH-, -CH 2 C(O)N(CH 3 )-, -CH 2 C(O)NHCH 2 -, or -CH 2 C(O)NHCH 2 CH 2 -; R 1 is -CH 2 CH 3 or -CH(CH 3 ) 2 ; each R 2 is independently -CH 3 or -OCH 3 ; R2a is -CH 3 ; each R 2b is independently H, Cl, or -CH 3 ; R 6 is: (i) -CH 2 C(O)NHCH 2 C(CH 3 ) 2 OH, -CH 2 C(O)NHCH 2 CH 2 C(CH 3 ) 2 OH, -CH 2 C(O)NHCH 2 CH 2 NH 2 , or -CH 2 C(O)NHCH 2 CHFC(CH 3 ) 2 OH; or (ii) azabicyclo[3.2.1]octanyl, azaspiro[5.5]undecanyl, azetidinyl, cyclohexyl, diazabicyclo[2.2.1]heptanyl, diazaspiro[3.5]nonanyl, imidazolyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, phenyl, piperazinyl, piperidinyl, pyrrolidinyl, pyridinyl, or quinuclidinyl, each substituted with zero to 2 R 6a ; (i) -CH 2 C(O)NHCH 2 C(CH 3 ) 2 OH, -CH 2 C(O)NHCH 2 CH 2 C(CH 3 ) 2 OH, -CH 2 C(O)NHCH 2 CH 2 NH 2 , or -CH 2 C(O)NHCH 2 CHFC(CH 3 ) 2 OH; or (ii) azabicyclo[3.2.1]octanyl, azaspiro[5.5]undecanyl, azetidinyl, cyclohexyl, diazabicyclo[2.2.1]heptanyl, diazaspiro[3.5]nonanyl, imidazolyl, morpholinyl, octahydrocyclopenta[c]pyrrolyl, phenyl, piperazinyl, piperidinyl, pyrrolidinyl, pyridinyl, or quinuclidinyl, each substituted with zero to 2 R 6a ; each R 6 a is independently F, -OH, -CH 3 , -CH 2 CH 2 CH 3 , -C(CH 3 ) 2 , -CH 2 CH(CH 3 ) 2 , -CH 2 CH 2 CF 3 , -CH 2 CH 2 CH 2 CF 3 , -CH 2 CH 2 OH, -CH 2 CH 2 CH 2 OH, -CH 2 CH(CH 3 )OH, -CH 2 C(CH 3 ) 2 OH, -CH 2 CH 2 OCH 3 , -NH 2 , -N(CH 3 ) 2 , -CH 2 NH 2 , -CH 2 CH 2 NH 2 , -CH 2 CH 2 S(O) 2 CH 3 , -CH 2 C(O)OH, -CH 2 C(O)N(CH 3 ) 2 , -C(O)CH 2 N(CH 3 ) 2 , -CH 2 (phenyl), morpholinyl, oxetanyl, tetrahydropyranyl, piperidinyl, isopropylpiperidinyl, isobutylpiperidinyl, or -O(piperidinyl); n is zero; and p is zero. <EOS>